Compendium of Cancer Genome Aberrations

Changes

Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations (view source)

Revision as of 15:28, 13 July 2020

212 bytes added ,  15:28, 13 July 2020
continued gene links
Line 213: Line 213:  
|6q16.3
 
|6q16.3
 
|Loss
 
|Loss
−
|''COQR, GRIK2''
+
|''[[COQR]], [[GRIK2]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 285: Line 285:  
|8q24.3
 
|8q24.3
 
|Gain
 
|Gain
−
|''MAPK15, TOP1MT, CYP11B11 (P450), ZNF41, 616, 707'' and ''ZNF517''
+
|''[[MAPK15]], [[TOP1MT]], [[CYP11B11]] (P450), ZNF41, 616, 707'' and ''ZNF517''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 314: Line 314:  
|9q34.3
 
|9q34.3
 
|Gain
 
|Gain
−
|''ZNF79, CDK9, SET''
+
|''[[ZNF79]], [[CDK9]], SET''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 336: Line 336:  
|10q23.31
 
|10q23.31
 
|Loss
 
|Loss
−
|''PTEN''
+
|''[[PTEN]]''
 
|Recurrent
 
|Recurrent
 
|2
 
|2
Line 365: Line 365:  
|11q13.1/q13.4
 
|11q13.1/q13.4
 
|Gain
 
|Gain
−
|''SCYL1, MAP3K11, CCND1, FGF4, FGF3, NUMA,'' and ''RELT''
+
|''[[SCYL1]], [[MAP3K11]], [[CCND1]], [[FGF4]], [[FGF3]], [[NUMA]],'' and ''[[RELT]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 379: Line 379:  
|11q22.1-q22.3
 
|11q22.1-q22.3
 
|Homozygous Loss
 
|Homozygous Loss
−
|BIRC3, BIRC2, MMP cluster
+
|[[BIRC3]], [[BIRC2]], MMP cluster
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 401: Line 401:  
|12p13.1
 
|12p13.1
 
|Loss
 
|Loss
−
|''CDKN1B, APOLD1''
+
|''[[CDKN1B]], [[APOLD1]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 416: Line 416:  
|13q14.11/q14.2
 
|13q14.11/q14.2
 
|Loss
 
|Loss
−
|''TNFSF11, RB1, P2RY5, RCBTB2''
+
|''[[TNFSF11]], [[RB1]], [[P2RY5]], [[RCBTB2]]''
 
|Poor prognostic marker
 
|Poor prognostic marker
 
|1
 
|1
Line 423: Line 423:  
|13q32.2
 
|13q32.2
 
|Loss
 
|Loss
−
|''TGDS''
+
|''[[TGDS]]''
 
|Recurrent
 
|Recurrent
 
|2
 
|2
Line 452: Line 452:  
|14q24.1-q24.3
 
|14q24.1-q24.3
 
|Loss
 
|Loss
−
|''MLH3''
+
|''[[MLH3]]''
 
|Recurrent
 
|Recurrent
 
|2
 
|2
Line 459: Line 459:  
|14q32.32
 
|14q32.32
 
|Homozygous Loss
 
|Homozygous Loss
−
|''RCOR1, TRAF3, AMN, CDC42BPB''
+
|''[[RCOR1]], [[TRAF3]], [[AMN]], [[CDC42BPB]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 474: Line 474:  
|15q24.1
 
|15q24.1
 
|Gain
 
|Gain
−
|''CYP11A1, ARID3B, CSK, etc.''
+
|''[[CYP11A1]], [[ARID3B]], [[CSK]], etc.''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 482: Line 482:  
|16p11.2
 
|16p11.2
 
|Loss
 
|Loss
−
|''TP53TG3''
+
|''[[TP53TG3]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 496: Line 496:  
|16q12.1-q12.2
 
|16q12.1-q12.2
 
|Homozygous Loss
 
|Homozygous Loss
−
|''CYLD, SALL1''
+
|''[[CYLD]], [[SALL1]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 503: Line 503:  
|16q24.3
 
|16q24.3
 
|Loss
 
|Loss
−
|CBFA2T3 and others
+
|''[[CBFA2T3]]'' and others
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 532: Line 532:  
|17p13
 
|17p13
 
|Loss
 
|Loss
−
|''ATP1B2, '''TP53''', WRAP5, EFNB3''
+
|''[[ATP1B2]], '''[[TP53]]''', [[WRAP5]], [[EFNB3]]''
 
|Predictive & prognostic
 
|Predictive & prognostic
 
|1
 
|1
Line 576: Line 576:  
|19p/ 19p13
 
|19p/ 19p13
 
|Gain
 
|Gain
−
|''ICAM4,ICAM4, IBCL2L12, TYK2, IL2,'' and ''DNMT1''
+
|''ICAM4,ICAM4, [[IBCL2L12]], [[TYK2]], [[IL2]],'' and ''[[DNMT1]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 628: Line 628:  
|22q21
 
|22q21
 
|mostly Gain
 
|mostly Gain
−
|''PRAME''
+
|''[[PRAME]]''
 
|Recurrent, Associated with relapse
 
|Recurrent, Associated with relapse
 
|2
 
|2
Line 657: Line 657:  
|Xp22.33
 
|Xp22.33
 
|Loss
 
|Loss
−
|''SHOX, CRLF2, IL3RA''
+
|''[[SHOX]], [[CRLF2]], [[IL3RA]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 678: Line 678:  
|Xq21.31-q21.32
 
|Xq21.31-q21.32
 
|Loss
 
|Loss
−
|''PABPC5, PCDHX''
+
|''[[PABPC5]], [[PCDHX]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 685: Line 685:  
|Xq27.3-q28
 
|Xq27.3-q28
 
|Gain
 
|Gain
−
|''AFF2, MTMR1, etc''
+
|''[[AFF2]], [[MTMR1]], etc''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/8377"